Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liquan Xue

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9Hiromitsu Hara, Chitose Ishihara, Arata Takeuchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2006
Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptorsDonghai Wang, Yun You, Pei-Chun Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2023
CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B CellsYongwei Zheng, Mei Yu, Yuhong Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2001
Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphomaQian Zhang, Puthryaveett N Raghunath, Liquan Xue, et al.
Expert Review of Anticancer Therapy|March 12, 2009
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapyThomas R Webb, Jake Slavish, Rani E George, et al.
Journal of Medicinal Chemistry|February 3, 2006
Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinaseRongshi Li, Liquan Xue, Tong Zhu, et al.
Nature Immunology|May 9, 2007
The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptorsHiromitsu Hara, Chitose Ishihara, Arata Takeuchi, et al.
Plos One|July 30, 2011
An evolutionary conserved role for anaplastic lymphoma kinase in behavioral responses to ethanolAmy W Lasek, Jana Lim, Christopher L Kliethermes, et al.
Blood|August 22, 2009
Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphomaZhaoyang Li, Hongsheng Wang, Liquan Xue, et al.
Cancer Discovery|March 28, 2013
Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancerJim Sang, Jaime Acquaviva, Julie C Friedland, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9Hiromitsu Hara, Chitose Ishihara, Arata Takeuchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2006
Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptorsDonghai Wang, Yun You, Pei-Chun Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2023
CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B CellsYongwei Zheng, Mei Yu, Yuhong Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2001
Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphomaQian Zhang, Puthryaveett N Raghunath, Liquan Xue, et al.
Expert Review of Anticancer Therapy|March 12, 2009
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapyThomas R Webb, Jake Slavish, Rani E George, et al.
Journal of Medicinal Chemistry|February 3, 2006
Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinaseRongshi Li, Liquan Xue, Tong Zhu, et al.
Nature Immunology|May 9, 2007
The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptorsHiromitsu Hara, Chitose Ishihara, Arata Takeuchi, et al.
Plos One|July 30, 2011
An evolutionary conserved role for anaplastic lymphoma kinase in behavioral responses to ethanolAmy W Lasek, Jana Lim, Christopher L Kliethermes, et al.
Blood|August 22, 2009
Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphomaZhaoyang Li, Hongsheng Wang, Liquan Xue, et al.
Cancer Discovery|March 28, 2013
Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancerJim Sang, Jaime Acquaviva, Julie C Friedland, et al.
Pageof 3